The Biomarx Experiment

PillDollar

“We want to maximize the number of new prescriptions…” “We want to identify people at risk at the earliest possible point…” Pharmaceutical marketers want to maximize the number of prescriptions in order to maximize profits. They see clinical trials as investments whose purpose was to increase sales of medicines, “Important clinical studies to conduct from Continue reading…

Direct-to-Consumer Ads

This is the opening challenge in a Direct-To-Consumer (DTC) television commercial for Nexium, first aired in 2004. The aim of the commercial is to connect directly with the experience of heartburn sufferers so that they see themselves in the persons in the ads whom we are then told suffer from acid reflux disease, a disease Continue reading…

»How I Read

desk-bridge

Notes on reading modes sent to a grad class: I wanted to respond to the questions raised during our class regarding what kind of a reading I have been doing over these weeks.  I see it as close (as opposed to general), constructive (as opposed to deconstructive), positive (as opposed to negative), generous (as opposed Continue reading…

+
-

»Inter-pill-ation and the instrumentalization of compliance

non-compliance-daniels

Compliance’s usefulness as a measure of prescribed treatment adherence by a patient has been its ability to index treatment success, and therefore help in ensuring and governing health. What these anthropologists have discovered, however, is that because of its function as an index, compliance has been itself instrumentalized and made to serve goals sometimes quite far from health.

+
-

»Drugs for Life

DrugsForLife-Dumit-Cover-rev

How Pharmaceutical Companies Define Our Health (2012 Duke University Press) Kindle version is now out! Hear my radio interview about Drugs for Life on BBC 4 Thinking Allowed Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product Continue reading…

+
-